194 related articles for article (PubMed ID: 20581467)
1. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
Schuster A; Schilling T; De Laurenzi V; Koch AF; Seitz S; Staib F; Teufel A; Thorgeirsson SS; Galle P; Melino G; Stremmel W; Krammer PH; Müller M
Cell Cycle; 2010 Jul; 9(13):2629-39. PubMed ID: 20581467
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.
Mundt HM; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
Biochem Biophys Res Commun; 2010 May; 396(2):335-41. PubMed ID: 20403333
[TBL] [Abstract][Full Text] [Related]
3. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.
Müller M; Schilling T; Sayan AE; Kairat A; Lorenz K; Schulze-Bergkamen H; Oren M; Koch A; Tannapfel A; Stremmel W; Melino G; Krammer PH
Cell Death Differ; 2005 Dec; 12(12):1564-77. PubMed ID: 16195739
[TBL] [Abstract][Full Text] [Related]
4. DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
Bantel H; Simon HU
Cell Cycle; 2010 Jul; 9(14):2710-1. PubMed ID: 20676032
[No Abstract] [Full Text] [Related]
5. Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway.
Seitz SJ; Schleithoff ES; Koch A; Schuster A; Teufel A; Staib F; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
Int J Cancer; 2010 May; 126(9):2049-66. PubMed ID: 19711344
[TBL] [Abstract][Full Text] [Related]
6. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
[TBL] [Abstract][Full Text] [Related]
7. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
8. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
[TBL] [Abstract][Full Text] [Related]
9. Effects of ΔNp73β on cisplatin treatment in colon cancer cells.
Lööf J; Pfeifer D; Ding Z; Sun XF; Zhang H
Mol Carcinog; 2012 Aug; 51(8):628-35. PubMed ID: 21837762
[TBL] [Abstract][Full Text] [Related]
10. One, two, three--p53, p63, p73 and chemosensitivity.
Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
[TBL] [Abstract][Full Text] [Related]
11. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.
Simões-Wüst AP; Sigrist B; Belyanskaya L; Hopkins Donaldson S; Stahel RA; Zangemeister-Wittke U
J Neurooncol; 2005 Mar; 72(1):29-34. PubMed ID: 15803372
[TBL] [Abstract][Full Text] [Related]
12. Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
González R; De la Rosa ÁJ; Rufini A; Rodríguez-Hernández MA; Navarro-Villarán E; Marchal T; Pereira S; De la Mata M; Müller-Schilling M; Pascasio-Acevedo JM; Ferrer-Ríos MT; Gómez-Bravo MA; Padillo FJ; Muntané J
PLoS One; 2017; 12(3):e0174326. PubMed ID: 28350813
[TBL] [Abstract][Full Text] [Related]
13. DeltaNp73beta is active in transactivation and growth suppression.
Liu G; Nozell S; Xiao H; Chen X
Mol Cell Biol; 2004 Jan; 24(2):487-501. PubMed ID: 14701724
[TBL] [Abstract][Full Text] [Related]
14. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
Sayan AE; Sayan BS; Findikli N; Ozturk M
Oncogene; 2001 Aug; 20(37):5111-7. PubMed ID: 11526499
[TBL] [Abstract][Full Text] [Related]
15. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
John K; Alla V; Meier C; Pützer BM
Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma.
Lau LM; Wolter JK; Lau JT; Cheng LS; Smith KM; Hansford LM; Zhang L; Baruchel S; Robinson F; Irwin MS
Oncogene; 2009 May; 28(19):2024-33. PubMed ID: 19363520
[TBL] [Abstract][Full Text] [Related]
17. p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation.
Melino G; Bernassola F; Ranalli M; Yee K; Zong WX; Corazzari M; Knight RA; Green DR; Thompson C; Vousden KH
J Biol Chem; 2004 Feb; 279(9):8076-83. PubMed ID: 14634023
[TBL] [Abstract][Full Text] [Related]
18. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
19. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
[TBL] [Abstract][Full Text] [Related]
20. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
